Ultromics Company

They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence. To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.


Technology: Artificial Intelligence, Computer Vision, Health Care, Health Diagnostics, Medical, Software
Industry: AI in Pharma, Data Processing
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 12
Total Funding: 58824943
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-08-16
Last Funding Type: Series B

Visit Website
Register and Claim Ownership